Antibodies News and Research

RSS

Logical Biological and Bcell Design announce strategic partnership for engineered disease state materials

Logical Biological, biospecimen and critical raw material leader, and Bcell Design, pioneers in transgenic monoclonal antibody technology, today announced a long term strategic partnership to deliver engineered disease state materials for diagnostic and research markets.

From Logical Biological 7 Oct 2025

FDA grants approval to begin Phase I clinical trials of heart tissue regeneration drug AD-NP1

The body's tissues can get injured in many ways, but while some injuries heal perfectly, others don't heal at all. A cut in the skin, for example, usually heals all on its own, while internal organs, such as the heart after a heart attack or the kidney after an acute injury, remain damaged, leading to diminished function.

6 Oct 2025

Azelastine nasal spray prevents COVID-19 and rhinovirus infections

Researchers discuss the effects of azelastine nasal spray on the rate of SARS-CoV-2 infection as compared to placebo.

6 Oct 2025

Enzyme technology enables first successful blood type conversion in kidney transplant

The first successful human transplant of a kidney converted from blood type A to universal type O used special enzymes developed at the University of British Columbia to help prevent a mismatch and rejection of the organ.

3 Oct 2025

New study shows why HIV health recovery fails despite antiretroviral therapy

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never recover their health, even with antiretroviral treatment?

3 Oct 2025

Boosting the immune system to prevent cancer recurrence and improve survival

In experiments with mouse models of breast, pancreatic, and muscle cancers, researchers at Johns Hopkins All Children's Hospital report new evidence that a novel means of boosting the natural immune system prevents cancer recurrence and improves survival.

30 Sep 2025

New mRNA vaccine stops allergens from causing life-threatening inflammation in mice

A new mRNA vaccine stopped allergens from causing dangerous immune reactions and life-threatening inflammation in mice, according to researchers from the Perelman School of Medicine at the University of Pennsylvania and Cincinnati Children's.

29 Sep 2025

New evidence shows blood-brain barrier remains intact in Alzheimer's mouse model

A team of scientists at Texas Tech University Health Sciences Center (TTUHSC) has published new evidence suggesting that the brain's protective shield - known as the blood-brain barrier (BBB) - remains largely intact in a commonly used mouse model of Alzheimer's disease.

29 Sep 2025

Super-resolution imaging unlocks the role of transporter nanoclusters in tumor metabolism

Serine serves as a metabolic nexus in tumors, coordinating one-carbon metabolism, nucleotide synthesis, and redox regulation. In recent years, targeting the serine metabolic pathway, particularly the rate-limiting enzyme PHGDH, has attracted considerable attention as a promising anticancer strategy.

29 Sep 2025

New intramuscular mRNA vaccine offers easier alternative to treat neovascular eye diseases

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models.

26 Sep 2025

Targeting TGF-β signaling as a strategy to treat liver fibrosis

Liver fibrosis, a pathological scarring process resulting from chronic liver injury, represents a significant global health burden due to its potential progression to cirrhosis and hepatocellular carcinoma.

25 Sep 2025

New study reveals silent onset of rheumatoid arthritis

Scientists have discovered that rheumatoid arthritis (RA) doesn't start when the pain begins. It silently starts years earlier.

24 Sep 2025

Blocking iron-regulating enzyme triggers cancer cell death in multiple myeloma

Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of current therapies against the disease.

24 Sep 2025

Review shows lecanemab and donanemab slow decline and explains who should get them

The Lancet review synthesises evidence on anti beta amyloid monoclonal antibodies and the wider Alzheimer’s care pathway, weighing efficacy, safety, economics, and health system readiness across disease, patient, and population perspectives.

24 Sep 2025

Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease

A new Lancet review proposes a three-wave diagnostic pathway that combines clinical expertise with blood, CSF, and PET biomarkers. This approach aims to deliver earlier, more accurate, and more equitable Alzheimer’s disease diagnosis worldwide.

24 Sep 2025

NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus

Crimean-Congo hemorrhagic fever virus, or CCHFV, is a biosafety level 4 pathogen and a Category A bioterrorism agent, causing severe viral hemorrhagic fever with mortality rates reaching up to 40%.

24 Sep 2025

Far-UV at 222 nm disrupts common allergens and could ease asthma triggers

Far-UV radiation demonstrates a 25% reduction in airborne allergens, highlighting its promise for enhancing indoor air quality for asthma patients.

24 Sep 2025

New microfluidic-based biosensing platform helps track live antibody secretion dynamics

A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong Ye from the University of Texas San Antonio, has developed a new microfluidic-based biosensing platform that allows monitoring cellular secretion of monoclonal antibody in real time.

23 Sep 2025

New PET tracer enables rapid imaging of aggressive breast and bladder cancers

A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative breast and urothelial bladder cancers within four hours, according to new research published in the September issue of The Journal of Nuclear Medicine.

22 Sep 2025

UV222 light shows promise in disabling airborne allergens indoors

Cats. Dust mites. Mold. Trees. For people with allergies, even a brief whiff of the airborne allergens these organisms produce can lead to swollen eyes, itchy skin and impaired breathing.

22 Sep 2025

Antibodies News and Research

Logical Biological and Bcell Design announce strategic partnership for engineered disease state materials

FDA grants approval to begin Phase I clinical trials of heart tissue regeneration drug AD-NP1

Azelastine nasal spray prevents COVID-19 and rhinovirus infections

Enzyme technology enables first successful blood type conversion in kidney transplant

New study shows why HIV health recovery fails despite antiretroviral therapy

Boosting the immune system to prevent cancer recurrence and improve survival

New mRNA vaccine stops allergens from causing life-threatening inflammation in mice

New evidence shows blood-brain barrier remains intact in Alzheimer's mouse model

Super-resolution imaging unlocks the role of transporter nanoclusters in tumor metabolism

New intramuscular mRNA vaccine offers easier alternative to treat neovascular eye diseases

Targeting TGF-β signaling as a strategy to treat liver fibrosis

New study reveals silent onset of rheumatoid arthritis

Blocking iron-regulating enzyme triggers cancer cell death in multiple myeloma

Review shows lecanemab and donanemab slow decline and explains who should get them

Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease

NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus

Far-UV at 222 nm disrupts common allergens and could ease asthma triggers

New microfluidic-based biosensing platform helps track live antibody secretion dynamics

New PET tracer enables rapid imaging of aggressive breast and bladder cancers

UV222 light shows promise in disabling airborne allergens indoors

Antibodies eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo